CClinicalTrials.gg
CompletedNCT02027142Updated May 4, 2017

Sleep Quality, Daytime Sleepiness and Insomnia in Patients With Endometriosis: a Case-control Study.

An observational study in Endometriosis and Sleep, sponsored by IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. Completed at 2 sites in Italy. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2017-05-04.

Sponsored by IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy · Observational

Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
290
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

This study included women referred to two academic centres for the diagnosis and treatment of endometriosis (cases) and women referred to our Institutions because of routine gynaecologic consultations (controls). In this age-matched case-control study, the aimdy was to assess quality of sleep, the average daytime sleepiness and insomnia in patients with endometriosis by using three different self-reported questionnaires.

02

Conditions studied

03

In context

Disorders of Excessive Somnolence

173 studies on the registry are indexed under Disorders of Excessive Somnolence; 34 are open to participants now.

This study's enrollment of 290 is above the median of 110 across 32 observational studies indexed under Disorders of Excessive Somnolence.

Browse Disorders of Excessive Somnolence studies →

Lead sponsor

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy is the lead sponsor of 31 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

In this study were recruited women referred to two academic centres for the diagnosis and treatment of endometriosis (cases) and women referred to our Institutions because of routine gynaecologic consultations (controls).

Inclusion criteria

Reproductive age Surgical and histological diagnosis of rectovaginal endometriosis

Exclusion criteria

Exclusion Criteria:

Suspicion of endometriosis (based on evaluation of symptoms, gynaecological examination and transvaginal ultrasonography) History of infertility Previous diagnosis of endometriosis Gynaecological, intestinal and urological diseases causing abdominal pain (e.g. pelvic congestion syndrome, bladder pain syndrome) Severe underlying comorbidities (cardiovascular, respiratory, renal, hematological, endocrine, hepatic, gastrointestinal, neurological, or psychiatric) Pregnancy at any gestational age Suspicion or diagnosis of oncological pathology Use of gonadotropin releasing hormone analogues (GnRH-a) Restless legs syndrome Shift work Use of antiallergic drugs Narcotics Refusal or inability to sign the informed consent form or complete the study questionnaires

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
290 participants (actual)
Patient registry
No

Groups and cohorts

  • Cases

    Women referred to two academic centres for the diagnosis and treatment of endometriosis.

    Other: Pittsburgh Sleep Quality Index. · Other: Epworth sleepiness scale. · Other: Insomnia Severity Index. · Other: The Endometriosis Health Profile.

  • Controls

    Women referred to our Institutions because of routine gynaecologic consultations.

    Other: Pittsburgh Sleep Quality Index. · Other: Epworth sleepiness scale. · Other: Insomnia Severity Index.

Interventions

  • OtherPittsburgh Sleep Quality Index.

    Pittsburgh Sleep Quality Index is an effective instrument used to measure the quality and patterns of sleep of patients. It allows evaluating "poor" from "good" sleep by assessing seven domains. A total score ≤ 5 indicated good sleep quality while a total score \> 5 was indicated poor sleep quality.

  • OtherEpworth sleepiness scale.

    Epworth sleepiness scale is an 8-item questionnaire developed to measure average daytime sleepiness. A total score ≥ 10 indicates excessive daytime sleepiness.

  • OtherInsomnia Severity Index.

    Insomnia Severity Index is a 7-item questionnaire developed to measure insomnia. A total score between 0 and 7 correspond to not clinically significant insomnia, between 8 and 14 to subthreshold insomnia, between 15 and 21 to clinical insomnia (moderate), between 22 and 28 to clinical insomnia (severe).

  • OtherThe Endometriosis Health Profile.

    The Endometriosis Health Profile is a patient generated instrument that evaluates disease-specific health-related quality of life in patients with endometriosis. The questionnaire is administrable to all patients with endometriosis and it consists in 30 items divided in 5 domains (pain, control and powerlessness, emotional well-being, social support and self-image). Each scale for each domain is comprised between 0 (indicating the best health status) and 100 (indicating the worst health status).

06

What researchers measure

Primary outcomes

  1. Quality of sleep.

    Quality of sleep was assessed by using the Pittsburgh Sleep Quality Index.

    Time frame: Cases were administered and fulfilled the questionnaires at the moment of being scheduled for surgery (3-4 months before the operation). Controls were administered and fulfilled the questionnaires after routine gynaecologic consultation.

Secondary outcomes

  1. Average daytime sleepiness.

    Average daytime sleepiness was assessed by using the Epworth sleepiness scale.

    Time frame: Cases were administered and fulfilled the questionnaires at the moment of being scheduled for surgery (3-4 months before the operation). Controls were administered and fulfilled the questionnaires after routine gynaecologic consultation.

  2. Insomnia.

    Insomnia was assessed by using the Insomnia Severity Index.

    Time frame: Cases were administered and fulfilled the questionnaires at the moment of being scheduled for surgery (3-4 months before the operation). Controls were administered and fulfilled the questionnaires after routine gynaecologic consultation.

07

Study locations

2 sites
  • IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro
    Genoa, Ligury 16122, Italy
  • IRRCS San Raffaele Hospital and Vita-Salute San Raffaele University
    Milan, Lombardy 20132, Italy
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02027142
Lead sponsor
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Responsible party
Umberto Leone Roberti Maggiore (MD, IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy) — Principal investigator
First posted
Jan 3, 2014
Start date
May 2012
Primary completion
Dec 2013
Completion
Dec 2013
Last update
May 4, 2017

Study contacts

Umberto Leone Roberti Maggiore, MD
principal investigator · IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Simone Ferrero, PhD
study director · IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Stefano Salvatore, MD
principal investigator · IRRCS San Raffaele Hospital and Vita-Salute San Raffaele University of Milan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion